MELBOURNE AustraliaAustralias antitrust regulator has launched court proceedings against the local arm of Pfizer Inc alleging it misused its market power in the sale of a popular cholesterollowering drug The Australian Competition and Consumer Commission in a statement Thursday said its action in the federal court relates to offers made to drugstores in early  for the supply of Lipitor and Pfizers generic variant atorvastatin